These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 7663491

  • 1. Long-term intervention in childhood asthma: the Dutch study results. Dutch Chronic Nonspecific Lung Disease Study Group.
    van Essen-Zandvliet EE.
    Monaldi Arch Chest Dis; 1995 May; 50(3):201-7. PubMed ID: 7663491
    [Abstract] [Full Text] [Related]

  • 2. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group.
    van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Kerrebijn KF.
    Eur Respir J; 1994 Jan; 7(1):63-8. PubMed ID: 7908268
    [Abstract] [Full Text] [Related]

  • 3. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group.
    Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, Kerrebijn KF.
    Am Rev Respir Dis; 1993 Nov; 148(5):1252-7. PubMed ID: 8239161
    [Abstract] [Full Text] [Related]

  • 4. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.
    van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF.
    Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640
    [Abstract] [Full Text] [Related]

  • 5. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.
    Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EE, Kerrebijn KF.
    Thorax; 1999 Feb; 54(2):103-7. PubMed ID: 10325912
    [Abstract] [Full Text] [Related]

  • 6. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW, van der Mark TW, Koëter GH, Postma DS.
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [Abstract] [Full Text] [Related]

  • 7. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group.
    Waalkens HJ, van Essen-Zandvliet EE, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol K.
    Eur Respir J; 1993 May; 6(5):652-6. PubMed ID: 8519374
    [Abstract] [Full Text] [Related]

  • 8. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ, Clark MM, Oborne J, Bennett JA, Tattersfield AE.
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [Abstract] [Full Text] [Related]

  • 9. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma.
    Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE.
    Am Rev Respir Dis; 1991 Jun; 143(6):1317-21. PubMed ID: 2048819
    [Abstract] [Full Text] [Related]

  • 10. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
    Cockcroft DW, Swystun VA, Bhagat R.
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
    [Abstract] [Full Text] [Related]

  • 11. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
    Yates DH, Kharitonov SA, Barnes PJ.
    Eur Respir J; 1997 Jul; 10(7):1483-8. PubMed ID: 9230234
    [Abstract] [Full Text] [Related]

  • 12. Does ketotifen have a steroid-sparing effect in childhood asthma?
    Canny GJ, Reisman J, Levison H.
    Eur Respir J; 1997 Jan; 10(1):65-70. PubMed ID: 9032494
    [Abstract] [Full Text] [Related]

  • 13. Asthma control during and after cessation of regular beta 2-agonist treatment.
    Wahedna I, Wong CS, Wisniewski AF, Pavord ID, Tattersfield AE.
    Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655
    [Abstract] [Full Text] [Related]

  • 14. Minor acute effect of an inhaled corticosteroid (budesonide) on bronchial hyperresponsiveness to methacholine in children with asthma.
    van Essen-Zandvliet EE, Hop WC, de Jong H, Ferwerda A, Kerrebijn KF.
    Eur Respir J; 1993 Mar; 6(3):383-6. PubMed ID: 8472829
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G.
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms.
    Dahl R, Larsen BB, Venge P.
    Respir Med; 2002 Jun; 96(6):432-8. PubMed ID: 12117043
    [Abstract] [Full Text] [Related]

  • 17. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
    Harrison TW, Oborne J, Wilding PJ, Tattersfield AE.
    Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
    [Abstract] [Full Text] [Related]

  • 18. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH, Kharitonov SA, Barnes PJ.
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [Abstract] [Full Text] [Related]

  • 19. Tolerance to beta-agonists during acute bronchoconstriction.
    Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR.
    Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
    [Abstract] [Full Text] [Related]

  • 20. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U, Viktrup L, Davidsen O, Viskum K.
    Ugeskr Laeger; 1992 Nov 16; 154(47):3325-8. PubMed ID: 1361083
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.